Filing Details
- Accession Number:
- 0001562180-17-000234
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-01-13 15:51:58
- Reporting Period:
- 2017-01-13
- Filing Date:
- 2017-01-13
- Accepted Time:
- 2017-01-13 15:51:58
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1597553 | Sage Therapeutics Inc. | SAGE | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1304815 | Kimi Iguchi | C/O Sage Therapeutics, Inc. 215 First Street Cambridge MA 02142 | Cfo, Secretary And Treasurer | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2017-01-13 | 10,000 | $53.92 | 66,498 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- The sales reported on this Form 4 were effected pursuant to a trading plan adopted pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
- This transaction was executed in multiple trades at prices ranging from $53.72 USD to $54.33 USD; the price reported above reflects the weighted average sale price.
- These shares include prior ESPP purchases.